Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Industry News (Diagnostics)
New Technology Makes More Genetic Tests Feasible
November 20th, 1995
Integrated Genetics, Cambridge, Massachusetts, has developed a new genetic diagnostic technology that can simultaneously analyze hundreds of patient DNA samples for the presence of more than a hundred mutations in a single test. To validate the technology, Integrated Genetics analyzed DNA samples from 500 patients for the presence of 106 different mutations on seven genes. The results of this research were presented at a meeting of the American Society of Human Genetics, held in Minneapolis, Minnesota, in October 1995. The new technology, called Multiple Allele-Specific Diagnostic Assay (MASDA), makes it technically feasible to conduct the complex...
Source: Cancer Weekly (1995-11-20)
|
